Nu Skin Enterprises Stock Performance
| NUS Stock | USD 7.55 0.33 4.57% |
The company owns a Beta (Systematic Risk) of 0.35, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nu Skin's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nu Skin is expected to be smaller as well. At this point, Nu Skin Enterprises has a negative expected return of -0.25%. Please make sure to verify Nu Skin's treynor ratio, as well as the relationship between the accumulation distribution and period momentum indicator , to decide if Nu Skin Enterprises performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Nu Skin Enterprises has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 7.89 | Five Day Return 3.32 | Year To Date Return (61.66) | Ten Year Return (81.41) | All Time Return (72.90) |
Forward Dividend Yield 0.0332 | Payout Ratio 0.2143 | Forward Dividend Rate 0.24 | Dividend Date 2024-12-11 | Ex Dividend Date 2024-11-29 |
| Nu Skin dividend paid on 11th of September 2024 | 09/11/2024 |
1 | New Data Gen Z Most Likely to Trust Influencer Gift Recommendations, but Need the Most Touchpoints for a Sell | 10/03/2024 |
2 | STATE STREET CORPs Strategic Reduction in Nu Skin Enterprises Inc Holdings | 10/18/2024 |
3 | Acquisition by Emma Battle of 4232 shares of Nu Skin subject to Rule 16b-3 | 10/30/2024 |
4 | E.l.f. Beauty Q2 Earnings and Revenues Beat Estimates | 11/06/2024 |
5 | Nu Skin Enterprises Reports Third Quarter Results | 11/07/2024 |
6 | Nu Skin Enterprises Inc Q3 2024 Earnings Call Highlights Navigating Challenges with ... | 11/08/2024 |
7 | Acquisition by Ryan Napierski of 21513 shares of Nu Skin at 30.63 subject to Rule 16b-3 | 11/11/2024 |
8 | Does Nu Skin Enterprises Have A Healthy Balance Sheet | 11/12/2024 |
| Begin Period Cash Flow | 264.7 M |
NUS |
Nu Skin Relative Risk vs. Return Landscape
If you would invest 919.00 in Nu Skin Enterprises on August 27, 2024 and sell it today you would lose (164.00) from holding Nu Skin Enterprises or give up 17.85% of portfolio value over 90 days. Nu Skin Enterprises is generating negative expected returns assuming volatility of 3.3284% on return distribution over 90 days investment horizon. In other words, 29% of stocks are less volatile than NUS, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Nu Skin Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nu Skin's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nu Skin Enterprises, and traders can use it to determine the average amount a Nu Skin's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0758
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NUS |
Estimated Market Risk
| 3.33 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nu Skin is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nu Skin by adding Nu Skin to a well-diversified portfolio.
Nu Skin Fundamentals Growth
NUS Stock prices reflect investors' perceptions of the future prospects and financial health of Nu Skin, and Nu Skin fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NUS Stock performance.
| Return On Equity | -0.13 | ||||
| Return On Asset | 0.0555 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 622.91 M | ||||
| Shares Outstanding | 49.71 M | ||||
| Price To Earning | 10.70 X | ||||
| Price To Book | 0.51 X | ||||
| Price To Sales | 0.20 X | ||||
| Revenue | 1.97 B | ||||
| Gross Profit | 1.59 B | ||||
| EBITDA | 137.66 M | ||||
| Net Income | 8.6 M | ||||
| Cash And Equivalents | 264.73 M | ||||
| Cash Per Share | 7.69 X | ||||
| Total Debt | 607.33 M | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 14.22 X | ||||
| Cash Flow From Operations | 118.64 M | ||||
| Earnings Per Share | (2.09) X | ||||
| Market Capitalization | 358.91 M | ||||
| Total Asset | 1.81 B | ||||
| Retained Earnings | 1.87 B | ||||
| Working Capital | 373 M | ||||
| Current Asset | 706.39 M | ||||
| Current Liabilities | 407.6 M | ||||
About Nu Skin Performance
Assessing Nu Skin's fundamental ratios provides investors with valuable insights into Nu Skin's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Nu Skin is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 167.02 | 141.74 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Equity | 0.01 | 0.01 |
Things to note about Nu Skin Enterprises performance evaluation
Checking the ongoing alerts about Nu Skin for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nu Skin Enterprises help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nu Skin Enterprises generated a negative expected return over the last 90 days | |
| Nu Skin Enterprises has high historical volatility and very poor performance | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Does Nu Skin Enterprises Have A Healthy Balance Sheet |
- Analyzing Nu Skin's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nu Skin's stock is overvalued or undervalued compared to its peers.
- Examining Nu Skin's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nu Skin's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nu Skin's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nu Skin's stock. These opinions can provide insight into Nu Skin's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.